Literature DB >> 23825780

Value of delayed 18F-FDG PET in the diagnosis of solitary pulmonary nodule.

Ali Nawaz Khan1, Hamdan Al-Jahdali.   

Abstract

Performing dual point 18F-FDG PET scans of solitary pulmonary nodules at an initial SUV (max) <2.5 is a useful technique. However, prolonging second image acquisition from 120 to 180 min does not appear to improve accuracy. Dual time 18F-FDG PET is not useful in differentiating benign and malignant pulmonary nodules with an initial mean SUV ≤2.5 in parts of the world where granulomatous disease is prevalent. Prolonged imaging on PET scanners is expensive particularly where availability if these scanners is limited. Further prospective research is required to define the potential benefits of dual time point 18F-FDG PET imaging, before recommending routine use of the technique.

Entities:  

Keywords:  Solitary pulmonary nodules; dual-point scan18F-FDG PET scans

Year:  2013        PMID: 23825780      PMCID: PMC3698279          DOI: 10.3978/j.issn.2072-1439.2013.06.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  14 in total

1.  Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.

Authors:  Yan Xiu; Chirdeep Bhutani; Thiruvenkatasamy Dhurairaj; Jian Q Yu; Simin Dadparvar; Swapna Reddy; Rakesh Kumar; Hua Yang; Abass Alavi; Hongming Zhuang
Journal:  Clin Nucl Med       Date:  2007-02       Impact factor: 7.794

2.  Management of solitary pulmonary nodule.

Authors:  Federico Varoli; Contardo Vergani; Rocco Caminiti; Massimo Francese; Camillo Gerosa; Marco Bongini; Giancarlo Roviaro
Journal:  Eur J Cardiothorac Surg       Date:  2008-01-18       Impact factor: 4.191

3.  The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.

Authors:  K Macdonald; J Searle; I Lyburn
Journal:  Clin Radiol       Date:  2010-12-31       Impact factor: 2.350

4.  The value of delayed (18)F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patients.

Authors:  Peng Yang; Xiao-Yang Xu; Xiao-Jing Liu; Jing-Shan Gong
Journal:  Quant Imaging Med Surg       Date:  2011-12

5.  Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis.

Authors:  Li Zhang; Yinzhong Wang; Junqiang Lei; Jinhui Tian; Yanan Zhai
Journal:  Acta Radiol       Date:  2013-04-30       Impact factor: 1.990

Review 6.  Potential value of dual-time-point ¹⁸F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis.

Authors:  Yu-Yi Lin; Jin-Hua Chen; Hueisch-Jy Ding; Ji-An Liang; Jun-Jun Yeh; Chia-Hung Kao
Journal:  Nucl Med Commun       Date:  2012-10       Impact factor: 1.690

7.  The calcified lung nodule: What does it mean?

Authors:  Ali Nawaz Khan; Hamdan H Al-Jahdali; Carolyn M Allen; Klaus L Irion; Sarah Al Ghanem; Shyam Sunder Koteyar
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

8.  Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

Authors:  Hiroaki Nomori; Kenichi Watanabe; Takashi Ohtsuka; Tsuguo Naruke; Keiichi Suemasu; Kimiichi Uno
Journal:  Lung Cancer       Date:  2004-07       Impact factor: 5.705

9.  Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

Authors:  Chao-Jung Chen; Bi-Fang Lee; Wei-Jen Yao; Lili Cheng; Pei-Shan Wu; Ching Lin Chu; Nan-Tsing Chiu
Journal:  AJR Am J Roentgenol       Date:  2008-08       Impact factor: 3.959

10.  Fluorine-18-fluorodeoxyglucose uptake in pneumonia.

Authors:  L O Kapucu; C C Meltzer; D W Townsend; R J Keenan; J D Luketich
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

View more
  1 in total

1.  Size of solitary pulmonary nodule was the risk factor of malignancy.

Authors:  Chang-Zheng Shi; Qian Zhao; Liang-Ping Luo; Jian-Xing He
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.